Tissue engineering is a technique that engage the practice of combining scaffolds, biologically active molecules and cells to develop functional tissues as an alternative to natural ones. The main objective of tissue engineering is to make use of functional construct that can ultimately restore, maintain and improve damaged tissues and organs through improving the recovery process and chances of survival.
Tissue engineering substitute are of two types, acellular and cellular. Cellular products comprises living cells such as fibroblasts and keratinocytes enclosed within a matrix. Acellular products include matrix composed of materials such as hyaluronic acid, collagen, and fibronectin.
According to the American Burn Association (ABA), about 1 million burn injuries occur annually in the United States, burn injuries result in approximately 4500 deaths.
Tissue Engineered Skin Substitute Market: Drivers and Restraints
Presently, tissue engineered skin substitute global market is driven by the technological advancement in healthcare industry, increasing research funding, inclination of researchers towards development of tissue engineered skin, increase in the incidence of burn injuries and other skin diseases. However, inability of reproducing skin appendages, and lack of capability to replace the lost tissue especially the dermis are some major barriers for this market.
Tissue Engineered Skin Substitute Market: Segmentation
Tissue engineered skin substitute global market is segmented into following types:
By Product Type
Synthetic Skin Substitute
Biosynthetic Skin Substitute
Biological Skin Substitute
Diabetic Foot Ulcers
By End Users
Other Healthcare Facilities
Tissue Engineered Skin Substitute Market: Overview
With rapid technological advancement, increasing research funding, and increase in the incidence of burn injuries and other skin diseases, the tissue engineered skin substitute global market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).
Request Report Sample with TOC@ http://www.futuremarketinsights.com/reports/sample/rep-gb-781
Tissue Engineered Skin Substitute Market: Region-wise Outlook
Depending on geographic regions, tissue engineered skin substitute global market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe is expected to capture the largest market shares followed by Asia Pacific countries where the market is expected to grow due to rapid technological innovations, large consumer base, and high disposable income.
Tissue Engineered Skin Substitute Market: Key Players
Some of the key participating players in tissue engineered skin substitute market are Organogenesis, Inc., Smith & Nephew Plc, BSN medical GmbH, Covidien Plc., Regenicin Inc., Integra LifeSciences Corporation, Shire Plc., Molnlycke Health Care AB and others.